Cargando…

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer

The most frequent malignancy of the pancreas is the pancreatic ductal adenocarcinoma (PDAC). Despite many efforts PDAC has still a dismal prognosis. Biomarkers for early disease stage diagnosis as a prerequisite for a potentially curative treatment are still missing. Novel blood-based markers may he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Andreas W., Schwerdel, Daniel, Reinacher-Schick, Anke, Uhl, Waldemar, Algül, Hana, Friess, Helmut, Janssen, Klaus-Peter, König, Alexander, Ghadimi, Michael, Gallmeier, Eike, Bartsch, Detlef K., Geissler, Michael, Staib, Ludger, Tannapfel, Andrea, Kleger, Alexander, Beutel, Alica, Schulte, Lucas-Alexander, Kornmann, Marko, Ettrich, Thomas J., Seufferlein, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401492/ https://www.ncbi.nlm.nih.gov/pubmed/30867830 http://dx.doi.org/10.7150/thno.29247

Ejemplares similares

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
por: Ettrich, Thomas J., et al.
Publicado: (2018)

Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
por: Berger, Andreas W., et al.
Publicado: (2017)

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
por: Berger, Andreas W., et al.
Publicado: (2017)

A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response
por: Beutel, Alica K., et al.
Publicado: (2021)

Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
por: Roger, Elodie, et al.
Publicado: (2020)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
por: Ettrich, T. J., et al.
Publicado: (2019)

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
por: Perkhofer, L., et al.
Publicado: (2019)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
por: Kurreck, A., et al.
Publicado: (2020)

Adjuvant therapy in colorectal cancer – studies of the FOGT group
por: Staib, Ludger, et al.
Publicado: (2010)

Pluripotency Factors on Their Lineage Move
por: Weidgang, Clair E., et al.
Publicado: (2016)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study
por: Müller, Martin, et al.
Publicado: (2015)

The Impact of Bioactive Lipids on Cardiovascular Development
por: Kleger, Alexander, et al.
Publicado: (2011)

Enteropathogenic Infections: Organoids Go Bacterial
por: Hentschel, Viktoria, et al.
Publicado: (2021)

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome
por: Faissner, Simon, et al.
Publicado: (2016)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
por: Melzer, Michael Karl, et al.
Publicado: (2020)

Differentiation of human pluripotent stem cells into pancreatic duct-like organoids
por: Breunig, Markus, et al.
Publicado: (2021)

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Microbial Spectra and Clinical Outcomes from Endoscopically Drained Pancreatic Fluid Collections: A Descriptive Cohort Study
por: Hentschel, Viktoria, et al.
Publicado: (2022)

A Systematic Comparative Study on the Diagnostic Value of Transabdominal Ultrasound in Patients with Pancreatic Cystic Lesions
por: Hentschel, Viktoria, et al.
Publicado: (2022)

Label-free, automated classification of microsatellite status in colorectal cancer by infrared imaging
por: Kallenbach-Thieltges, Angela, et al.
Publicado: (2020)

A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab
por: Backhus, Johanna, et al.
Publicado: (2021)

Whipple Resection for Benign Tumors and Premalignant Neoplasms of the Pancreatic Head: Surgery-Associated Risk for Complications and Late Metabolic Morbidity Matters
por: Beger, Hans G., et al.
Publicado: (2023)

The COVID-19 pandemic: impact on surgical departments of non-university hospitals
por: Stöß, Christian, et al.
Publicado: (2020)

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial
por: Stintzing, Sebastian, et al.
Publicado: (2018)

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
por: Budczies, Jan, et al.
Publicado: (2022)

Definitive Endoderm Formation from Plucked Human Hair-Derived Induced Pluripotent Stem Cells and SK Channel Regulation
por: Illing, Anett, et al.
Publicado: (2013)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
por: Perkhofer, Lukas, et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

A Double Metachronous Ureter Metastasis following Curative Resection of Rectal Cancer
por: Aghalarov, Ilgar, et al.
Publicado: (2021)

IFN-γ treatment protocol for MHC-I(lo)/PD-L1(+) pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential
por: Stifter, Katja, et al.
Publicado: (2020)

Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoids
por: Merz, Sarah, et al.
Publicado: (2023)

Protocol for MInimizing the Risk of Metachronous Adenomas of the CoLorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population
por: Stingl, Julia C, et al.
Publicado: (2011)

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma
por: Ettrich, Thomas J., et al.
Publicado: (2016)

Complete mesocolic excision for right colonic cancer: prospective multicentre study
por: Benz, Stefan R, et al.
Publicado: (2022)

Colorectal Adenoma – Resection Techniques and Surveillance
por: Kähler, Georg, et al.
Publicado: (2014)

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
por: Reinacher-Schick, Anke, et al.
Publicado: (2012)

Barriers and opportunities for gemcitabine in pancreatic cancer therapy
por: Beutel, Alica K., et al.
Publicado: (2023)

Reprogramming to pluripotency does not require transition through a primitive streak-like state
por: Raab, Stefanie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b1sj6ofgld2kt71993mrinad1g